Bioorganic & Medicinal Chemistry Letters 2010-01-01

Coumarins as novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer.

Koichiro Harada, Hideki Kubo, Yoshitaka Tomigahara, Kazuhiko Nishioka, Junya Takahashi, Mio Momose, Shinichi Inoue, Atsuyuki Kojima

Index: Bioorg. Med. Chem. Lett. 20 , 272-5, (2010)

Full Text: HTML

Abstract

The synthesis and SAR studies of 3- and 4-substituted 7-hydroxycoumarins as novel 17beta-HSD3 inhibitors are discussed. The most potent compounds from this series exhibited low nanomolar inhibitory activity with acceptable selectivity versus other 17beta-HSD isoenzymes and nuclear receptors.Copyright 2009 Elsevier Ltd. All rights reserved.

Related Compounds

  • 4-Methylumbellifer...
  • 7-Hydroxy-4-(trifl...

Related Articles:

Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term.

2015-12-01

[Eur. J. Drug Metab. Pharmacokinet. 40 , 471-80, (2015)]

Cell protrusions induced by hyaluronan synthase 3 (HAS3) resemble mesothelial microvilli and share cytoskeletal features of filopodia.

2015-10-01

[Exp. Cell Res. 337 , 179-91, (2015)]

DNA-Linked Enzyme-Coupled Assay for Probing Glucosyltransferase Specificity.

2015-07-17

[ACS Synth. Biol. 4 , 833-41, (2015)]

The combination of plant translational enhancers and terminator increase the expression of human glucocerebrosidase in Nicotiana benthamiana plants.

2015-11-01

[Plant Sci. 240 , 41-9, (2015)]

Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.

2015-01-01

[Drug Metab. Dispos. 43(1) , 34-41, (2014)]

More Articles...